We were not able to find studies reporting the participation of LYPD3 (LY6/PLAUR Domain Containing 3, also known as C4.4A), a urokinase-type plasminogen activator receptor (uPAR) homolog, in kidney diseases. This evidence concerns the gene PLAUR and kidney disorder.